John H. Dillon II serves as Executive at ENCYSIVE PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, John H. Dillon II has executed 6 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 1, 2008 involved transacting 9,121 shares valued at $21.4K.
John H. Dillon II currently holds 9,121 shares of ENCYSIVE PHARMACEUTICALS INC (ENCY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John H. Dillon II has been a net neutral trader of ENCY stock. They have purchased $0 and sold $0 worth of shares.
John H. Dillon II's most recent insider trade was on Apr 1, 2008, when they sold 9,121 shares at $2.35 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 2, 2006 | ENCY | $0 | Other | 1,744 | $N/A | Discretionary |
| Jul 10, 2006 | ENCY | $0 | Other | 1,106 | $N/A | Discretionary |
| Mar 31, 2006 | ENCY | $0 | Other | 1,503 | $N/A | Discretionary |
| Dec 31, 2005 | ENCY | $0 | Other | 950 | $N/A | Discretionary |